FR3018357B1 - Nouvelles lectines et applications pour la detection de marqueurs d'etats pathologiques - Google Patents

Nouvelles lectines et applications pour la detection de marqueurs d'etats pathologiques Download PDF

Info

Publication number
FR3018357B1
FR3018357B1 FR1451740A FR1451740A FR3018357B1 FR 3018357 B1 FR3018357 B1 FR 3018357B1 FR 1451740 A FR1451740 A FR 1451740A FR 1451740 A FR1451740 A FR 1451740A FR 3018357 B1 FR3018357 B1 FR 3018357B1
Authority
FR
France
Prior art keywords
lectines
applications
detection
new
modules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1451740A
Other languages
English (en)
Other versions
FR3018357A1 (fr
Inventor
Anne Imberty
Aymeric AUDFRAY
Julie ARNAUD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Joseph Fourier Grenoble 1
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Joseph Fourier Grenoble 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Joseph Fourier Grenoble 1 filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1451740A priority Critical patent/FR3018357B1/fr
Priority to US15/123,138 priority patent/US10247734B2/en
Priority to PCT/IB2015/051422 priority patent/WO2015132699A1/fr
Priority to EP15711300.2A priority patent/EP3114487A1/fr
Publication of FR3018357A1 publication Critical patent/FR3018357A1/fr
Application granted granted Critical
Publication of FR3018357B1 publication Critical patent/FR3018357B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4724Lectins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Lectines multimériques avec une architecture de type β-propeller, formées de modules monomères d'environ de 30 à 60 acides aminés, dans lesquels les sites de fixation aux glycanes sont situés d'un même côté des protéines et les extrémités C-ter et N-ter des chaînes peptidiques de l'autre côté des protéines, caractérisées en ce qu'elles sont formées de 4 à 7 modules monomères, un seul, ou plusieurs ou la totalité des modules adjacents étant reliés entre eux par des linkers liant l'extrémité N-terminale d'un module à l'extrémité C-terminale du module adjacent.
FR1451740A 2014-03-04 2014-03-04 Nouvelles lectines et applications pour la detection de marqueurs d'etats pathologiques Expired - Fee Related FR3018357B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1451740A FR3018357B1 (fr) 2014-03-04 2014-03-04 Nouvelles lectines et applications pour la detection de marqueurs d'etats pathologiques
US15/123,138 US10247734B2 (en) 2014-03-04 2015-02-26 Lectins and applications for the detection of pathological state markers
PCT/IB2015/051422 WO2015132699A1 (fr) 2014-03-04 2015-02-26 Nouvelles lectines et applications pour la détection de marqueurs d'états pathologiques
EP15711300.2A EP3114487A1 (fr) 2014-03-04 2015-02-26 Nouvelles lectines et applications pour la détection de marqueurs d'états pathologiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1451740A FR3018357B1 (fr) 2014-03-04 2014-03-04 Nouvelles lectines et applications pour la detection de marqueurs d'etats pathologiques
FR1451740 2014-03-04

Publications (2)

Publication Number Publication Date
FR3018357A1 FR3018357A1 (fr) 2015-09-11
FR3018357B1 true FR3018357B1 (fr) 2018-05-18

Family

ID=51210510

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1451740A Expired - Fee Related FR3018357B1 (fr) 2014-03-04 2014-03-04 Nouvelles lectines et applications pour la detection de marqueurs d'etats pathologiques

Country Status (4)

Country Link
US (1) US10247734B2 (fr)
EP (1) EP3114487A1 (fr)
FR (1) FR3018357B1 (fr)
WO (1) WO2015132699A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110420671A (zh) * 2019-06-26 2019-11-08 南京科瑞芯生物科技有限公司 一种凝集素微阵列芯片及其制备方法
FR3116062A1 (fr) 2020-11-06 2022-05-13 Centre National De La Recherche Scientifique (Cnrs) Neolectine specifique et son utilisation pour detecter des microorganismes

Also Published As

Publication number Publication date
EP3114487A1 (fr) 2017-01-11
FR3018357A1 (fr) 2015-09-11
US10247734B2 (en) 2019-04-02
WO2015132699A1 (fr) 2015-09-11
US20170074887A1 (en) 2017-03-16

Similar Documents

Publication Publication Date Title
PH12018502367A1 (en) Antigen binding molecules comprising a tnf family ligand trimer and pd1 binding moiety
PH12017500892A1 (en) Antigen binding molecules comprising a tnf family ligand trimer
MX2019004681A (es) Moleculas basadas en il-15 multimericas.
EA201400488A1 (ru) Полипептидные конструкции и их применение
EA201491599A1 (ru) Антитела к матриксной металлопротеиназе 9
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
EA201792245A1 (ru) Биоконъюгаты и их применения
MX2022006461A (es) Anticuerpos anti-axl, fragmentos de anticuerpos y sus inmunoconjugados y usos de los mismos.
EA201491575A1 (ru) Антитела к матриксной металлопротеиназе 9
CY1123615T1 (el) Πολυσθενεις και πολυειδικες συντηγμενες πρωτεïνες που δεσμευουν τον dr5
PE20170768A1 (es) Anticuerpos de union a protofibrillas ab mejorados
WO2016007870A3 (fr) Motifs de reconnaissance immunitaire
FR3018357B1 (fr) Nouvelles lectines et applications pour la detection de marqueurs d'etats pathologiques
WO2017072222A9 (fr) Conception basée sur une structure de ligands de protéine d
FR3016888B1 (fr) Synthetases de la colistine et cluster de genes correspondants
EA201891333A1 (ru) Фактор viii с увеличенным периодом полужизни и уменьшенными способностями по связыванию лигандов
MA47671A (fr) Molécules de liaison d'antigène comprenant un trimère de ligand de la famille tnf
TH181764A (fr)
RU2012141166A (ru) Модификация дрожжевой двугибридной системы, которая позволяет значительно повысить эффективность тестирования взаимодействия между белками
TH1801002037A (th) แอนติบอดีต่อ cd19 ของมนุษย์ที่มีสัมพรรคภาพสูง
TH1701000544A (th) แอนติ-ctla4 โมโนโคลนอล แอนติบอดีหรือชิ้นส่วนย่อยที่เข้าจับแอนติเจน ของสารนั้น, องค์ประกอบทางเภสัชกรรมและการใช้
TH179215A (th) วาเรียนท์โปรตีนของลำดับกรดอะมิโน Cry1Da1 ที่มีฤทธิ์ต่อ Lepidopteran
TH175948A (th) พอลิเปปไทด์ที่เป็นแอนติเจนของ wt1 และสารต้านมะเร็งที่ประกอบด้วย พอลิเปปไทด์นั้น
TH180920A (th) แอนติบอดีซึ่งจับเกะากับ fcrn สำหรับการรักษาโรคภูมิต้านตนเอง
TH178681A (th) สารยึดติด

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20211105